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1. Introduction
Atrial ﬁbrillation is a serious clinical problem, which is associated
with systemic thrombosis such as cerebral infarction. Pulmonary vein
myocardiumpromotes andmaintains atrial ﬁbrillation. Catheter ablation
is done to cure atrial ﬁbrillation to cut down the current ﬂow from
pulmonary vein myocardium.
Although pulmonary vein thrombi (PVT) are thought to be a rare
complication of certain tumors of the lung [1], lobectomy, bilobectomy,
lung transplantation [2] or radiofrequency ablation for atrial ﬁbrillation
[3], I have reported several cases in patients without such conditions,
which represent that PVT are not rare in patients without such
conditions [4,5]. Recently, I have reported 61% of 57 elderly patients
with chest pain [6], indicating PVT may be common in elderly
patients with chest pain. I have reported them using 64-slice
multidetector CT (64-MDCT), indicating 64-MDCT is a useful tool to
diagnose PVT.
Presently, the relationship between PVT and atrial ﬁbrillation
remains unknown. In this paper, I show a patientwith paroxysmal atrial
ﬁbrillation (PAF) that had PVT, for the ﬁrst time.2. Case report
The patient was a 78 year-old-male with hyperlipidemia and PAF.
He had been treated with bezaﬁbrate (100 mg 2T bid), but no previous
treatment with warfarin or new oral anticoagulants (NOAC) had been
performed. The electrocardiogram (ECG) showed normal sinus rhythm,
normal axis and normal heart rate (74 beats/min). SerumD-dimer level
was b0.5 μg/ml (normal; b1.0 μg/ml), the activity of protein Swas 124%
(normal; 60–150%), and the activity of protein C was 72% (normal;
64–146%). The patient had no symptoms of lung cancer or cerebral
infarction. The patient had no lung surgery or catheter ablation. 64-
MDCT was performed for the evaluation of chest pain. 64-MDCT
illustrated no coronary artery stenosis, but illustrated thrombi in the
lower branch of the left upper pulmonary vein (LUPV) (Fig. 1; coronal
and Fig. 2; sagittal) as the defect of contrast enhancements. After
three month dabigatran therapy, PVT did not dissolve signiﬁcantly.http://dx.doi.org/10.1016/j.ijcha.2014.10.006
2352-9067/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access articlThis is the ﬁrst case that showed thrombi in the lower branch of the
LUPV in a patient with PAF, and the patient had no history of cerebral
infarction.
I have reported several cases of PVT [4–6], which represents that PVT
may be common in elderly patients with chest pain. Although PVT are
possible cause of cerebral infarction, the effects of PVT are not fully
understood. To clarify these effects, more studies are needed.
Blood stasis and hypercoagulability are two crucial predisposing
factors for the development of venous thrombosis. In this case,
serum D-dimer level, the activity of protein S, and the activity of
protein C were within normal range.
In the conference of Basic Cardiovascular Sciences (BCVS) 2014, Kim
EJ and their colleagues [7] reported that they generated vascular smooth
cell-speciﬁc Tuberous sclerosis complex 1 (TSC1) haplo-insufﬁcient
knockout mouse (TSC1SM22+/−). They observed that the arterial
thrombus area and the neointima formation were increased in
TSC1SM22+/−mice compared with that of WT mice, indicating that
the pathology of TSC1 in smooth cells plays roles in thrombus formation
and neointima formation. TSC1 seemed to play roles to inhibit a
thrombus formation and a neointima formation. Pathology of TSC1
is a possible cause of a PVT formation. Moreover pathology of TSC1
may play a role in the neointima formation, indicating new possibilities
of modulating pulmonary vein myocardium that is associated with the
progression andmaintenance of AF. There is a possibility that pathology
of TSC1 may generate and progress PVT formation. Much more studies
are needed to clarify this possibility.
PVT can release microclots that occlude microvessels in all organs.
Recanalization can rescue microvessel occlusions in mice [8]. Occlusion
of pulmonary veins or arteries in all organs by thrombi, if recanalization
fails, makes them hypoxia and undernourishment, which effects are not
fully understood. Hypoxia and low glucose levels cause mitochondria
dysfunctions, which damage tissues by decreasing ATP production and
increasing reactive oxygen species (ROS). Hypoxia activates transcription
factors; hypoxia inducible factors (HIFs) and the lack of glucose can
activate nuclear respiratory factor-1 (NRF-1), which is well known to
regulate the genes associated with mitochondria. Pulmonary ﬁbrosis is
reported to be associated with PVT [9]. Occlusion of the pulmonary vein
may make effects on pulmonary vein myocardium transformation via
HIFs and NRF-1 activation. HIFs and NRF-1 may modulate pulmonary
ﬁbrosis. Occluded arteries by thrombi make similar effects on arterial
wall, which may cause neointimal formations. HIFs can cause
reprogramming via activation of JMJD2 protein family [10]. Such
reprogramming may play an important role in a thrombus formation,
neointimal formation and pulmonary vein myocardium modulation as
well as ﬁbrosis. More studies to clarify these mechanisms are required.
Warfarin [4] and dabigatran [5,6] dissolved thrombi partially in
pulmonary veins in some cases, but in this case, the thrombi didn't
dissolve signiﬁcantly. The lacks of enough pulmonary vein ﬂow may
prevent pulmonary vein thrombi from dissolving.e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. Coronal images showed an incomplete occlusion of the lower branch of the left
upper pulmonary vein (LUPV) as little contrast enhancements (arrows). LA; left atrium,
LUPV; left upper pulmonary vein.
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Fig. 2. Sagittal images showed an occlusion of the lower branch of the left upper pulmo-
nary vein (LUPV) as little contrast enhancements (arrow). LA; left atrium, LUPV; left
upper pulmonary vein, LV; left ventricle.
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Some parts of this paper including the relationship PVT and
mitochondria dysfunctions will be reported in Cell Symposia poster
session.• Cell Symposia; Systems Approach toMetabolic Diseases, 1–3 Oct 2014,
Chicago, IL, USA. “Pulmonary vein thrombi can injury mitochondria,
which deteriorates dementia, diabetes, cardiovascular disease and
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